Skip to main content
Emily Germain-Lee, MD, Pediatric Endocrinology, Farmington, CT

EmilyLucyGermain-LeeMD

Pediatric Endocrinology Farmington, CT

Pediatric Bone Metabolism Disorders, Pediatric Growth Disorder Endocrinology

Professor, Dept of Pediatrics, Univ of Connecticut School of Medicine; Professor, Dept of Reconstructive Sciences, Univ of Connecticut School of Dental Medicine; Head of Academic Affairs and Research, Pediatric Endocrinology and Diabetes, Connecticut Children's Additional: Director, Center for Rare Bone Disorders; Director, Albright Center; Director, Osteogenesis Imperfecta Center

Dr. Germain-Lee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Germain-Lee's full profile

Already have an account?

  • Office

    505 Farmington Ave
    Farmington, CT 06032
    Phone+1 860-837-6700
    Fax+1 860-837-6765

Summary

  • Dr. Emily Germain-Lee is a Professor of Pediatrics at the University of Connecticut School of Medicine and Professor of Reconstructive Sciences at the Univ of Connecticut School of Dental Medicine. She is also the Head of Academic Affairs and Research for Pediatric Endocrinology at Connecticut Children's as well as the Director for the Scientific Center for Rare Disease for Connecticut Children's Research Institute. Her research focus is on rare bone disorders, and she established and directs the Center for Rare Bone Disorders, Albright Center, and Osteogenesis Imperfecta Center. She is an NIH-funded laboratory investigator. She received her Bachelor's degree from Harvard University and her M.D. from Johns Hopkins University School of Medicine, where she also completed her residency and pediatric endocrinology fellowship. She then went on to be faculty at Johns Hopkins from 1992 -2016, achieving the rank of Professor. She moved to Connecticut at the end of 2016, and she remains a Professor (Adjunct) at Johns Hopkins. She has been in practice 32 years. She specializes in pediatric bone disorders, especially rare bone disorders, and pediatric growth disorders. Her laboratory focus is on Albright hereditary osteodystrophy, osteogenesis imperfecta, rare bone disorders, and general bone biology. She is experienced in rare bone disorders including pseudohypoparathyroidism (Albright hereditary osteodystrophy) and osteogenesis imperfecta, pediatric endocrinology, pediatric disorders of bone metabolism and genetic bone disorders

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Pediatric Endocrinology, 1989 - 1992
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Pediatrics, 1986 - 1989
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineInternship, Transitional Year, 1986 - 1987
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1986
  • Harvard University
    Harvard UniversityA.B., Biochemical Studies, magna cum laude, 1977 - 1981

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2016 - 2026
  • MD State Medical License
    MD State Medical License 1988 - 2026
  • NM State Medical License
    NM State Medical License 2017 - 2018
  • Pediatric Endocrinology
    American Board of Pediatrics Pediatric Endocrinology

Awards, Honors, & Recognition

  • Connecticut Academy of Science & Engineering 2019

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Next Generation of Weight Loss Drugs Being Researched at UConn
    Next Generation of Weight Loss Drugs Being Researched at UConnFebruary 25th, 2025
  • Advocates Fighting for Rare Disease Council
    Advocates Fighting for Rare Disease CouncilApril 8th, 2022
  • 2021 Research Innovators Named by UConn School of Medicine
    2021 Research Innovators Named by UConn School of MedicineDecember 21st, 2021
  • Join now to see all

Grant Support

  • Role of G protein-coupled signaling in neurocognitive and psychosocial abnormalitiesNIH2016–2019
  • Phase 2 Of Growth Hormone For Treatment Of Albright Hereditary OsteodystrophyFood And Drug Administration2010–2011
  • Growth Hormone Use In Pseudohypoparathyroidism Type 1AFood And Drug Administration2004–2008
  • Studies Of Hormone Action In Patients With Altered G Protein FunctionNational Center For Research Resources2004–2007
  • Molecular Basis Of Peroxisomal DisordersEunice Kennedy Shriver National Institute Of Child Health &Human Development1992–1996